weight regain after stopping semaglutide trial The returns. Here's what your prescriber may not have told you. The STEP 1 extension found that patients regained approximately two-thirds of their lost weight within one year of Weight loss and muscle loss.

The most common side effects, reported in at least 5% of people being treated with Ozempic in clinical trials of the drug, were: nausea vomiting diarrhea abdominal pain constipation These side effects were typically mild and became less bothersome with time

Symptoms include fatigue, shortness of breath, light-headedness, dizziness, and a fast heartbeat

Bearish Takeaways Mizuho also flags concentration risk, noting that the investment case is still tightly linked to the weight loss management program, which could leave the story sensitive to any changes in GLP-1 adoption or competitive dynamics

ACE/ARB, angiotensin converting enzyme inhibitors/angiotensin-receptor blockers Postop, Postprocedural

age, gender, diet, and exercise regimen

Lilly, which also has significant exposure to the weight-loss drug market, saw its stock come under pressure as well